by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Chemco Corporation Warning Letter Details

Warning Letter

Chemco Corporation

Recipient Name Mr. Eitelberg G. Montarroyos, Sr., 4920 NW 165th Street Miami Lakes , FL 33014-6323 United States

Issue DateApril 07, 2026

FEI Number1042599

Violations9

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated

Chemco Corporation FDA Warning Letter, April 7, 2026